Optime CareOptime Care
  • Home
  • About
  • Leadership
  • Stories
  • Careers
  • Contact
  • Home
  • About
  • Leadership
  • Stories
  • Careers
  • Contact
Optime Care Featured in HIT Consultant Industry Publication: Critical Role of a Specialty Pharmacist in the Management of Orphan and Rare Diseases
News

Optime Care Featured in HIT Consultant Industry Publication: Critical Role of a Specialty Pharmacist in the Management of Orphan and Rare Diseases

By Donovan Quill January 13, 2021 No Comments

Optime Care Pharmacist-in-charge, Dr. Brandon Salke, PHARM.D, byline article featured on January 8, 2020: Why A Patient-First Strategy for Specialty Rx Pharmacists Is Critical to Optimize Outcomes

One of the biggest challenges for biopharmaceutical manufacturers of products for rare and orphan disease patient populations is optimizing disease management in a way that enhances the patient journey and improves outcomes. As these companies seek innovative solution partners, a patient-first approach that offers specialty Rx pharmacist expertise is critical for securing insurance coverage, coordinating care, ensuring compliance and, ultimately, minimizing the daily impact of rare and orphan diseases.

In today’s challenging healthcare environment, biopharma companies need to feel confident that their products are properly and safely transported and promptly distributed, with reimbursements processed quickly and accurately. As described in this article,  the  best approach is to partner with a pharmacy, distribution, and patient management organization that offers a patient-first strategy for rare and orphan disorders, as well as personalized care programs designed to maximize the benefit of the therapies prescribed for patients. The goal is to improve quality of life for both patient and caregiver with a dedicated support system for positive outcomes and long-term well-being.

Ideally, one phone call with a patient can begin the process of optimizing medication delivery, insurance reimbursement, compliance and education based on a plan tailored for each patient’s specific needs.

 

Tags:

Brandon SalkeHIT Consultant Industry PublicationOptime CareRare and orphan disorderrare and orphan drugsSpecialty pharmacistSpecialty Pharmacy
Love1
Share Tweet Share 0 Share Pin

Rare Voices Home

Categories

  • Articles (8)
  • News (14)
  • Podcast (7)

RSS Rare Voices Podcast

  • S1E4: Bill Jollie, Global Pharmaceutical September 24, 2020
  • S1E3: Ken Greathouse, serial entrepreneur and philanthropist July 7, 2020
  • S1E2: Jim Clement, Coues Consulting July 7, 2020

Listen to Rare Voices on:

Apple iTunes
Soundcloud
Stitcher
Spotify

Related Posts

News
January 5, 2021

Optime Care Featured in Today’s Geriatric Medicine: Highlights Benefits of Patient-First Model for Meeting Needs of Seniors with Rare and Orphan Diseases

Donovan Quill
News
January 4, 2021

Optime Care Featured in HIT Consultant Industry Publication: High Tech Meets High Touch

Donovan Quill
News
December 8, 2020

Optime Care Featured in Healthcare Business Today: Specialty Rx Pharmacists Play Critical Role Supporting Caregivers of Patients with Rare and Orphan Diseases

Donovan Quill

Stay Informed

Optime Care Newsletter Signup

Privacy Policy
Orange County Web Design by Website Muscle
© 2020 Optime Care